Epigenetics
Epigenetic Regulation to Treat Acute Organ Injury and Chronic Liver Diseases
James E. Brown, D.V.M.
DURECT Corporation
PAP-Q2-20-CL-022Jul 01, 2020
Partnership
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-081Aug 21, 2018
Regenerative Medicine Therapies
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-079Aug 20, 2018
FDA Approval
FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
U.S. Food & Drug Administration
PR-M05-18-NI-094May 24, 2018